Avg closing price
Price range

2 Joel Greenblatt Trillium Therapeutics Trades

Joel Greenblatt started to build up the position in Trillium Therapeutics in Q3 2020. Since then they sold 13.7 Thousand shares. The investor sold all their shares in Q4 2020 and doesn't own any shares in Trillium Therapeutics anymore.

Avg closing price
Price range
Sold -13.7 Thousand shares Q4 2020
Avg closing price $14.42
Price range $11.63 - $20.13
New holding (+13.7 Thousand shares) Q3 2020
Avg closing price $9.97
Price range $6.56 - $16.00

Embed chart

Easily embed the chart on your blog or website – it will always update automatically!